Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who have received prior cisplatin-based therapy

被引：0
|
作者：
Shinohara, N
Suzuki, S
Abe, T
Sazawa, A
Harabayashi, T
Nonomura, K
机构：
来源：
JOURNAL OF UROLOGY | 2005年 / 173卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)35464-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1319
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [21] Cisplatin-based combination chemotherapy in elderly patients with metastatic urothelial cancer
    Bamias, Aristotelis
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Moshier, Erin L.
    Sonpavde, Guru
    Godbold, James H.
    Oh, William K.
    Koutras, Angelos
    Pu, Yeong-Shiau
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [22] Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer
    McKenzie, Hayley S.
    Mead, Graham
    Huddart, Robert
    White, Jeff D.
    Rustin, Gordon J. S.
    Hennig, Ivo M.
    Cozens, Kelly
    Cross, Nadia
    Bowers, Megan
    Wheater, Matthew J.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : 458 - +
  • [23] Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy
    Fujii, Hironori
    Iihara, Hirotoshi
    Kajikawa, Noriko
    Kobayashi, Ryo
    Suzuki, Akio
    Tanaka, Yoshihiro
    Yamaguchi, Kazuya
    Yoshida, Kazuhiro
    Itoh, Yoshinori
    ANTICANCER RESEARCH, 2017, 37 (12) : 6831 - 6837
  • [24] Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy
    Galsky, Matthew D.
    Moshier, Erin
    Krege, Susan
    Lin, Chia-Chi
    Hahn, Noah
    Ecke, Thorsten
    Sonpavde, Guru
    Godbold, James
    Oh, William K.
    Bamias, Aristotle
    CANCER, 2013, 119 (16) : 3012 - 3019
  • [25] A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
    Galsky, Matthew D.
    Hahn, Noah M.
    Rosenberg, Jonathan
    Sonpavde, Guru
    Hutson, Thomas
    Oh, William K.
    Dreicer, Robert
    Vogelzang, Nicholas
    Sternberg, Cora
    Bajorin, Dean F.
    Bellmunt, Joaquim
    LANCET ONCOLOGY, 2011, 12 (03): : 211 - 214
  • [26] Cisplatin-Ifosfamide-Gemcitabine as Salvage Chemotherapy in Ovarian Cancer Patients Pretreated with Platinum Compounds and Paclitaxel
    Polyzos, Aristides
    Tsavaris, Nikolas
    Gogas, Helen
    Lagadas, Antonios
    Polyzos, Kostas
    Giannakopoulos, Kostas
    Felekouras, Evangelos
    Tsigris, Christos
    Karatzas, Theodoros
    Papadopoulos, Othon
    Giannopoulos, Athanasios
    ANTICANCER RESEARCH, 2009, 29 (07) : 2681 - 2686
  • [27] Prognostic Factors for Metastatic Urothelial Carcinoma Undergoing Cisplatin-based Salvage Chemotherapy
    Taguchi, Satoru
    Nakagawa, Tohru
    Hattori, Mami
    Niimi, Aya
    Nagata, Masayoshi
    Kawai, Taketo
    Fukuhara, Hiroshi
    Nishimatsu, Hiroaki
    Ishikawa, Akira
    Kume, Haruki
    Homma, Yukio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (09) : 923 - 928
  • [28] Editorial Comment to Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors
    Miyake, Hideaki
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (03) : 293 - 293
  • [29] Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen
    Takahashi, T
    Higashi, S
    Nishiyama, H
    Segawa, T
    Nakamura, E
    Kinoshita, H
    Itoh, N
    Yamamoto, S
    Kamoto, T
    Habuchi, T
    Ogawa, O
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (02) : 104 - 108
  • [30] THE ROLE OF CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED UROTHELIAL TRACT CANCER
    YAGODA, A
    SEMINARS IN ONCOLOGY, 1989, 16 (04) : 98 - 104
12345